ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,115Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 4623

$1.46M Total Retail Price of All Prescriptions

Rank: 41 out of 4623

835 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

32% of this provider’s 835 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 16,713 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,050 794 1 2
HYDROCODONE-ACETAMINOPHEN 864 592 S3 2 3
LEVOTHYROXINE SODIUM 765 653 3 1
NEXIUM 756 606 4 17
AMLODIPINE BESYLATE 509 447 5 5
ALENDRONATE SODIUM 497 424 6 22
LISINOPRIL 485 378 7 4
METFORMIN HCL 455 351 8 6
FUROSEMIDE 426 343 9 8
METOPROLOL SUCCINATE 413 327 10 13
RANITIDINE HCL 373 285 11 47
METOPROLOL TARTRATE 373 309 11 9
ZOLPIDEM TARTRATE 369 265 13 18
JANUVIA 350 291 14 52
DONEPEZIL HCL 340 329 15 30
OMEPRAZOLE 317 233 16 7
LOSARTAN POTASSIUM 303 263 17 21
CLOPIDOGREL 294 245 18 31
POTASSIUM CHLORIDE 291 255 19 14
CEFDINIR 277 217 20 129
CRESTOR 271 200 21 20
NYSTATIN 256 202 22 175
CEFUROXIME 243 175 23 152
TRAMADOL HCL 236 166 24 15
PRAVASTATIN SODIUM 233 162 25 11
PLAVIX 228 200 26 45
POLYETHYLENE GLYCOL 3350 196 159 27 91
LOSARTAN-HYDROCHLOROTHIAZIDE 192 177 28 46
ZETIA 189 152 29 92
IBUPROFEN 183 100 30 65
MUPIROCIN 180 138 31 159
NAPROXEN 177 131 32 63
INSULIN SYRINGE 176 135 33 85
SERTRALINE HCL 176 137 33 26
TAMSULOSIN HCL 169 147 35 29
NAMENDA 166 162 36 36
GLIPIZIDE 151 106 37 49
ISOSORBIDE MONONITRATE ER 151 143 37 60
BONIVA 145 134 39 314
GABAPENTIN 139 112 40 16
ATORVASTATIN CALCIUM 138 125 41 12
KETOPROFEN 138 92 41 397
NYSTATIN-TRIAMCINOLONE 137 103 43 199
GLYBURIDE 134 110 R 44 59
CILOSTAZOL 134 118 44 176
ZOSTAVAX 129 120 46 131
LANTUS 127 88 47 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 127 96 47 68
IBANDRONATE SODIUM 126 116 49 283
LYRICA 124 71 50 66
ACETAMINOPHEN-CODEINE 122 90 S3 51 144
AZITHROMYCIN 111 85 52 33
CYCLOBENZAPRINE HCL 110 93 R 53 53
NOVOLIN 70-30 107 79 54 153
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 97 55 19
HYDROCHLOROTHIAZIDE 103 88 56 10
NEOMYCIN-POLYMYXIN-HC 101 70 57 479
TRICOR 98 79 58 88
GLIMEPIRIDE 97 83 59 38
ESCITALOPRAM OXALATE 91 58 60 75
LEVOFLOXACIN 86 78 61 81
AVODART 83 73 62 172
LUNESTA 83 73 62 287
SYNTHROID 79 64 64 73
ATENOLOL 79 66 64 28
MEGESTROL ACETATE 78 70 R 66 145
GLYBURIDE-METFORMIN HCL 76 69 R 67 56
CARVEDILOL 74 67 68 25
DICLOFENAC SODIUM 74 69 68 121
GRIS-PEG 70 53 10 70 387
CIPROFLOXACIN HCL 69 57 71 43
LOVASTATIN 69 62 71 34
WARFARIN SODIUM 67 58 73 24
CARBIDOPA-LEVODOPA 67 59 73 116
FELODIPINE ER 64 64 75 174
PRANDIN 64 60 75 333
GEMFIBROZIL 62 56 77 94
CEFPROZIL 60 38 78 342
PROMETHAZINE HCL 59 24 R 79 93
JANUMET 59 41 79 136
LIPITOR 58 56 81 100
ENALAPRIL MALEATE 56 45 82 41
PANTOPRAZOLE SODIUM 56 43 82 35
SANTYL 55 53 84 213
LACTULOSE 55 31 84 106
NASONEX 54 30 86 171
HYDRALAZINE HCL 52 45 87 99
CEPHALEXIN 52 33 87 84
CHLORZOXAZONE 50 43 R 89 335
CYMBALTA 50 15 89 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.